
Pomegranate Health Review
Best for: budget-conscious shoppers
Telehealth provider offering some of the lowest compounded GLP-1 pricing on the market.
What the monthly price covers
Medication
Included
Provider visits
Not disclosed
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Pomegranate Health is one of the most affordable GLP-1 options on the market.
Pomegranate Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $90/mo
- What's included
- Medication · Shipping
- FDA status
- No FDA warning letter on record
How we scored Pomegranate Health
Each dimension is scored algorithmically from Pomegranate Health’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
9.2/10At $90/mo, Pomegranate Health runs about 47% below the $170 median for GLP-1 providers.
Effectiveness25%
8.2/10Pomegranate Health offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.0/10Online intake and platform experience; 3 platform features disclosed.
Trust & Safety15%
7.4/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-03).
Accessibility10%
6.2/10Pomegranate Health's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
6.0/10Pomegranate Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this Pomegranate Health review
Last checked 2026-06-03- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications Pomegranate Health offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Ready to get started?
Plans and promotions change often — check Pomegranate Health's current pricing and active discounts before you decide.
What we like
- Aggressively low monthly pricing
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
Watch-outs
- Limited public information on program details
Pomegranate Health: the price-first option for cost-driven shoppers
Pomegranate Health (joinpomegranate.com) is a telehealth provider built around a single, blunt promise: some of the lowest compounded GLP-1 pricing you'll find anywhere. Its starting compounded semaglutide runs about $90 a month, which lands well under the category median of $170. If your decision comes down almost entirely to monthly cost, Pomegranate belongs on your shortlist. But the same minimalism that keeps the price low also means the company publishes far less about itself than most rivals, and that trade-off is the heart of this review.
How the pricing actually works
Pomegranate sells compounded medication on a flat monthly basis, and the headline figure includes the drug itself plus shipping — the company says orders are "shipped discreetly to your door at no extra cost," so there's no separate delivery charge stacked on top. There is no teaser or first-month promo rate to lure you in and then jump; the low number is simply the number. Compounded tirzepatide costs more than the semaglutide tier, as it does at essentially every provider, but both sit at the aggressive end of the market.
One honest caveat on the math: pricing in this corner of telehealth moves, and Pomegranate's has drifted upward from what we first recorded. Treat the figures here as a ballpark and confirm the live monthly cost — and exactly what's bundled into it — on the checkout page before you commit. See our scoring methodology for how we weigh price against everything else.
The medications and how they're dispensed
Pomegranate offers two compounded GLP-1s: semaglutide (the active ingredient in Wegovy and Ozempic) and tirzepatide (the molecule behind Zepbound and Mounjaro). Both are compounded rather than brand-name, which is the lever that makes the low pricing possible — you are not paying a brand list price that can run well over a thousand dollars a month elsewhere. Medication and shipping are included in the monthly fee.
- Compounded semaglutide — the lowest-priced tier, around $90 a month with shipping included
- Compounded tirzepatide — a higher monthly cost, still priced aggressively for the dual-action molecule
- No brand-name option — if you specifically want FDA-approved Wegovy, Ozempic, Zepbound or Mounjaro, this isn't the provider for that
What genuinely sets Pomegranate apart
The real differentiator is simple and narrow: price. Pomegranate competes almost purely on monthly cost, with free discreet shipping rolled in. There's no elaborate membership tier, no coaching-heavy wellness platform layered on top, no upsell maze — just compounded medication delivered cheaply. For a budget-conscious patient who already knows they want a compounded GLP-1 and doesn't need hand-holding, that focus is genuinely appealing.
Where the thin disclosure becomes a real drawback
Here's the honest counterweight. Pomegranate publishes very little about the machinery behind the prescription. It does not name its compounding pharmacy publicly, and we have no accreditation detail on file for the pharmacy that fills your order — something better-documented competitors put front and center. The list of states it serves isn't disclosed on the site either; the company directs prospective patients to email support@joinpomegranate.com to check coverage, and we've seen indications that semaglutide isn't available in every state. None of this means the operation is unsafe — there are no FDA warning letters on file against it — but "no red flags we can see" is not the same as "transparently vetted," and you deserve to know the difference.
Who should choose it — and who should skip it
Choose Pomegranate if cost is your dominant constraint, you're comfortable with compounded medication, and you're willing to do a little legwork — emailing support to confirm your state, reading the current checkout terms — in exchange for a low monthly price. It's a reasonable fit for a returning GLP-1 user who knows the ropes and just wants affordable refills.
Skip it if you want a named, accredited pharmacy you can look up; if you need brand-name medication; if you value built-in coaching, dietitian access, or a polished support experience; or if you simply want a provider whose program details are all spelled out before you hand over payment. Patients who need more reassurance about oversight will be more comfortable with a provider that discloses its pharmacy and state coverage up front.
Trust and medical oversight
As a telehealth compounding service, Pomegranate operates in the same regulatory lane as its peers — a clinician review precedes any prescription, and the medication is compounded rather than mass-manufactured. We found no FDA enforcement actions tied to the company. That said, our verification confidence is limited by how little the provider shares: no public pharmacy name, no accreditation record, and no published state list. We'd rate the safety picture as "unremarkable but under-documented" rather than "strongly vouched for."
Bottom line
Pomegranate Health is a price play, and on price it delivers — compounded semaglutide near $90 a month with shipping included is hard to beat, and tirzepatide is competitive too. The cost of that low cost is transparency: you're trusting an operation that keeps its pharmacy, accreditation, and state coverage largely off the page. If you're a confident, budget-first shopper willing to confirm the current price and your state by email, it's a defensible choice. If you want everything documented before you buy, a more openly vetted provider will serve you better.
Shopping around? Telos Rx ($49/month) and bmiMD ($99/month) are the nearest alternatives to Pomegranate Health in our rankings.
Ready to start with Pomegranate Health?
Starting at $90/month. See current pricing and start your free consultation.
Alternatives to Pomegranate Health
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Pomegranate Health review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Pomegranate Health?
Starting at $90/month. See current pricing and start your free consultation.